Small Cell Lung Cancer - Epidemiology Market - A Booming Industry for the Investors! - PowerPoint PPT Presentation

Loading...

PPT – Small Cell Lung Cancer - Epidemiology Market - A Booming Industry for the Investors! PowerPoint presentation | free to download - id: 812936-YTEyM



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Small Cell Lung Cancer - Epidemiology Market - A Booming Industry for the Investors!

Description:

Download Sample Brochure @ A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Small Cell Lung Cancer - Epidemiology Review and future opportunities are provided in the report. – PowerPoint PPT presentation

Number of Views:14

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Small Cell Lung Cancer - Epidemiology Market - A Booming Industry for the Investors!


1
EpiCast Report Small Cell Lung Cancer -
Epidemiology Forecast to 2024
Published on 01 January, 2016 Single
User Price 3995 No of Pages 47
The report focuses on global major leading
industry players with information such as company
profiles, product picture and specifications,
sales, market share and contact information.
Whats more, the EpiCast Report Small Cell Lung
Cancer - Epidemiology Forecast to
2024 development trends and marketing channels
are analyzed.
2
Summary Small Cell Lung Cancer (SCLC) is a
distinct form of lung cancer that typically
initially presents in the central airways before
spreading to the submucosa, which leads to the
narrowing of airways. SCLC is considered to be
highly malignant due to its cell composition that
causes faster doubling time, earlier development
of metastases, and worsened prognosis when
compared with other lung cancer types. SCLC is
widely considered to account for 15 of all lung
cancer cases, with the other lung cancer cases
being predominantly caused by non-small cell lung
cancer (NSCLC). SCLC is typically presented in
two main stages, limited stage (LS-SCLC) and
extensive stage (ES-SCLC).
3
GlobalDatas epidemiological forecast for the
diagnosed incident and the five-year diagnosed
prevalent cases of SCLC in the 7MM is supported
by age- and sex-specific incidence data obtained
for the individual markets. Further, the analysis
was strengthened by the use of a consistent
methodology and definition of lung cancer for the
diagnosed incident cases in the SCLC forecast,
and using linear regression techniques when
suitable. In addition, the forecast is based on
age-, sex-, and market-specific historical data
points obtained from the NCC, CI5plus, ITACAN,
SEER, and ZfKD databases. The use of a consistent
methodology across the 7MM to forecast the total
diagnosed incident cases, and the five-year
diagnosed prevalent cases of SCLC, allows for a
meaningful comparison of the forecast incident
cases and the forecast five-year prevalent cases
of SCLC across the 7MM
Click Here To Check Complete Report
4
Scope - The Small Cell Lung Cancer (SCLC)
EpiCast Report provides an overview of the risk
factors, comorbidities, and global trends for RSV
infection in the seven major markets (7MM) (US,
France, Germany, Italy, Spain, UK, and Japan). It
includes a 10-year epidemiological forecast of
the diagnosed incident cases of SCLC and the
five-year diagnosed prevalent cases of SCLC
segmented by sex, age (beginning at 18 years and
ending at 85 years), and stage in these
markets. - The SCLC epidemiology report is
written and developed by Masters- and PhD-level
epidemiologists. - The EpiCast Report is
in-depth, high quality, transparent and
market-driven, providing expert analysis of
disease trends in the 10MM.
Download Sample Brochure
5
Reasons to buy The Small Cell Lung Cancer (SCLC)
EpiCast report will allow you to - - Develop
business strategies by understanding the trends
shaping and driving the global SCLC market. -
Quantify patient populations in the global SCLC
market to improve product design, pricing, and
launch plans. - Organize sales and marketing
efforts by identifying the sex and age groups
that present the best opportunities for SCLC
therapeutics in each of the markets covered.
Make an Inquiry Before Buying
6
Key questions answered in this report  What
will the market size be in 2020 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors? You can request one free
hour of our analysts time when you purchase this
market report. Details are provided within the
report.
7
EpiCast Report Small Cell Lung Cancer -
Epidemiology Forecast to 2024
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the, EpiCast Report Small Cell Lung Cancer -
Epidemiology Forecast to 2024 and future
opportunities are provided in the report.
Contact 1-302-684-6088 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of EpiCast Report
Small Cell Lung Cancer - Epidemiology Forecast to
2024
About PowerShow.com